Generics Industry News Search
 |
|
|
|
|
|
|
August 2011 News Archive |
 |
|
| |
|
Sun Pharmaceutical Industries Ltd announced that US FDA has granted its subsidiary a tentative approval for its abbreviated new drug application (ANDA) for generic version of Plavix...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug maker Ranbaxy Laboratories on Tuesday said the company and parent firm Daiichi Sankyo, are expanding their business in Mexico...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The US Patent and Trademark Officeis planning to reissue both the patents for Perforomist Inhalation Solution 20mcg/2ml vial to Dey Pharma, a subsidiary of Mylan.
...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Generics Inc USA, has bagged a final nod from the USFDA for its abbreviated new drug application...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Vectura Group has extended a deal with Sandoz for its generic lung drug VR315...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, the Company's wholly-owned generic subsidiary, to Zydus Pharmaceuticals and Zynesher Pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
POZEN Inc today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications seeking approval from the U.S. Food and Drug Administration to market generic copies of Treximet...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Multinational drug majors Pfizer and AstraZeneca have filed separate patent infringement cases against city-based Pharma Company Hetero Drugs in two different US courts....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Novartis contends that its patent on the drug should be extended as it has increased its efficacy by 30%, meaning that a person's capacity to absorb the newer version of the drug is that much better...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals today announced that its subsidiary, Watson Laboratories, has received tentative approval from the United States Food and Drug Administration for its Rosuvastatin zinc 5, 10, 20 and 40 mg tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Avanir Pharmaceuticals Inc is suing two generic drugmakers over patents protecting its drug Nuedexta, which the company started selling earlier this year...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Pharmaceuticals, on Friday announced the shipment of Alfuzosin hydrochloride extended release tablets, the generic version of Uroxatral...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A new FDA user-fee program will require generic drugmakers to pay annual fees to increase inspections of foreign manufacturing plants...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Endo Pharmaceuticals sued to stop Mylan Inc. from marketing a generic copy of Frova before three patents on the migraine drug expire...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz Inc a unit of the Swiss drug company Novartis AG, filed a federal lawsuit in Detroit seeking the courts finding that its proposed generic version of a Novo Nordisk A/S diabetes drug is non-infringing...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Vertex Pharmaceuticals Incorporated today announced that Health Canada has approved Incivek (Telaprevir) tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease including cirrhosis ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Spain's socialist government has passed a law forcing doctors and pharmacies to prescribe generic drugs rather than the more expensive brand names sold by pharmaceutical companies....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par Pharmaceutical Companies announced today that it entered into a definitive agreement to acquire Anchen Pharmaceuticals, a privately-held specialty pharmaceutical company focused on developing and commercializing extended release and niche generic products...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|